Funding new technologies for glaucoma treatment

Fostering innovation of new technologies for glaucoma is one focus of the Glaucoma Research Foundation, which in the past has highlighted over 95 new technologies, said Adrienne Graves, PhD, at the opening of the New Horizons Forum.

However, obtaining funding to foster those innovations is no easy task. The “friendly-fire” “Shark Tank” session, titled “Show me the Money––Getting to Go in Early Stage Glaucoma Financing,” gave innovators from Glint Pharmaceuticals, Qlaris Bio, Inc, and Smartlens, Inc, the opportunity to do just that and help one of the 3 presenters get their new product into the pipeline.